Mainz, Germany

Ozlem Tureci

USPTO Granted Patents = 53 


Average Co-Inventor Count = 4.8

ph-index = 10

Forward Citations = 264(Granted Patents)

Forward Citations (Not Self Cited) = 190(Oct 12, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal20 out of 50 
 
Ganymed Pharmaceuticals Ag
 patents
silverMedal15 out of 44 
 
Johannes Gutenberg-Universität Mainz
 patents
bronzeMedal13 out of 416 
 
Astellas Pharma Gmbh
 patents
411 out of 36 
 
Biontech Ag
 patents
57 out of 23 
 
Tron—translationale Onkologie An Der Universitátsmedizin Der Johannes Gutenberg—universitÄt Mainz Gemeinnützige Gmbh
 patents
64 out of 7 
 
Biontech Cell & Gene Therapies Gmbh
 patents
73 out of 10 
 
Ganymed Pharmaceuticals Gmbh
 patents
83 out of 14 
 
Tron-translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-universitat Mainz
 patents
92 out of 3 
 
Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-Universität Mainz Gemeinnützige Gmbh
 patents
102 out of 14 
 
UniversitÄtsmedizin Der Johannes Gutenberg-Universitat Mainz
 patents
112 out of 66 
 
Biontech Se
 patents
122 out of 4 
 
Johannes Gutenberg Universität
 patents
132 out of 15 
 
Tron—translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Ggmbh
 patents
141 out of 2 
 
Tron Ggmbh
 patents
151 out of 1 
 
Tron—translationale Onkologie An Der Untversitatsmedizin Der Johannes Gutenberg-Universit Mainz Ggmbh
 patent
161 out of 1 
 
Universitätsmedizin Der Johannes Gutenberg-Universität
 patent
171 out of 1 
 
Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenbera-Universität Mainz Gemeinnützine Gmbh
 patent
181 out of 1 
 
Tron—translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-Universitat At Mainz Gemeinnutzige Gmbh
 patent
191 out of 1 
 
Tron - Translationale Onkologie an Der Universitatsmedizin Der Johannes
 patent
201 out of 3 
 
Tron—translationale Onkologie An Der Universitat
 patents
211 out of 3 
 
Tron Translationale Onkologie an Der Universitatsm
 patents
221 out of 1 
 
Biontech Protein Therapeutics Gmbh
 patent
231 out of 1 
 
Tron—translationale Onkologie An Der Univresitätsmedizin Der Johannes Gutenberg-Universität Mainz Gemeinnützige Gmbh
 patent
241 out of 525 
 
Ludwig Institute for Cancer Research Limited
 patents
251 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...
Loading Chart...
53 patents (USPTO):Explore Patents

Title: Ozlem Tureci: Pioneering Medical Research and Innovation

Introduction:

Ozlem Tureci is a prominent figure in the field of medical research, having made significant contributions to the development of novel therapeutics for various diseases. Co-founder of the biotechnology company BioNTech, Tureci's expertise in the field of oncology has led to numerous milestones and recognition throughout his career.

Latest Patents:

Tureci's extensive contributions to medical research include the development of groundbreaking patents. His latest patents demonstrate his commitment to finding effective treatments for cancer-related diseases. One such patent involves the use of antibodies for the treatment of cancer expressing claudin 6. This innovation has the potential to address a wide range of tumor-related diseases including ovarian, lung, gastric, and breast cancer, among others. Additionally, Tureci's patent on a combination therapy involving antibodies against claudin 18.2 has shown promising results in the treatment of metastatic pancreatic adenocarcinoma.

Career Highlights:

Tureci's career has been marked by remarkable achievements in the field of medical research. With a total of 49 patents to his name, Tureci has consistently demonstrated his dedication to advancing the treatment of various diseases. His expertise transcends academia and into the business realm, as evidenced by his co-founding of BioNTech. This biotechnology company has quickly risen to prominence under his guidance, further solidifying Tureci's reputation as a leader in the industry.

Collaborations:

Throughout his career, Tureci has collaborated with esteemed professionals in the medical research field. Notable collaborators include Ugur Sahin and Michael Koslowski. Their combined expertise and collaborative efforts have paved the way for groundbreaking advancements in cancer treatment.

Conclusion:

Ozlem Tureci's exceptional contributions to medical research, highlighted by his numerous patents and innovative therapies, have positioned him as a trailblazer in the field. Through his co-founding of BioNTech and collaborations with renowned experts, Tureci continues to revolutionize the treatment of various cancers. His tireless dedication and commitment to innovation serve as an inspiration to aspiring researchers and inventors alike, leaving an indelible impact on the field of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…